Genetic polymorphism of the renin-angiotensin system and organ damage in essential hypertension

Kidney International

Volumn 57, Issue 2, 2000, Pages 561-569

  Pontremoli, Roberto ^a   Ravera, Maura ^a   Viazzi, Francesca ^a   Nicolella, Clizia ^a   Berruti, Valeria ^a   Leoncini, Giovanna ^a   Giacopelli, Francesca ^a   Bezante, Gian Paolo ^a   Sacchi, Giorgio ^a   Ravazzolo, Roberto ^a   Deferrari, Giacomo ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

ACE gene; Blood pressure; Cardiovascular disease; Microalbuminuria; Renin angiotensin aldosterone system

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; OPHTHALMOSCOPY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0033945850     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00876.x     Document Type: Article

References (58)

1. 1. RIGAT B, HUBERT C, ALHENC-GELAS F, CAMBIEN F, CORVOL P, SOUBRIER F: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346, 1990
2. 2. COSTEROUSSE O, ALLEGRINI J, LOPEZ M, ALHENC-GELAS F: Angiotensin I-converting enzyme in human circulating mononuclear cells: Genetic polymorphism of expression in T-lymphocytes. Biochem J 290:33-40, 1993
3. 3. JEUNEMAITRE X, SOUBRIER F, KOTELEVTSEV Y, LIFTON R, WILLIAMS C, CHARRU A, HUNT S, HOPKINS P, WILLIAMS R, LALOUEL JM, CORVOL P: Molecular basis of human hypertension: The role of angiotensinogen. Cell 71:169-180, 1992
4. 4. TIRET L, RIGAT B, VISVIKIS S, BREDA C, CORVOL P, CAMBIEN F, SOUBRIER F: Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 51:197-205, 1992
5. 5. SCHUNKERT H, HENSE HW, HOLMER SR, STENDER M, PERZ S, KEIL U, LORELL BH, RIEGGER GA: Association between a deletion polymorphism of the angiotensin converting enzyme gene and left ventricular hypertrophy. N Engl J Med 330:1634-1638, 1994
6. 6. IWAI N, OHMICHI N, NAKAMURA Y, KINOSHITA M: DD genotype of the angiotensin converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation 90:2622-2628, 1994
7. 7. LINDPAINTNER K, LEE M, LARSON MG, RAO VS, PFEFFER MA, ORDOVAS JM, SCHAEFER EJ, WILSON AF, WILSON PWF, VASAN RS, MYERS RH, LEVY D: Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and ventricular mass. N Engl J Med 334:1023-1028, 1996
8. 8. CAMBIEN F, POIRIER O, LECERF L, EVANS A, CAMBOU JP, ARVEILER D, LUC G, BARD JM, BARA L, RICARD S: Deletion polymorphism in the gene for angiotensin converting enzyme is a potent risk factor for myocardial infarction. Nature 359:641-644, 1992
9. 9. LINDPAINTNER K, PFEFFER MA, KREUTZ R, STAMPFER MJ, GROSTEIN F, LAMOTTE F, BURING J, HENNEKENS CH: A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 332:706-711, 1995
10. 10. NAKAI K, ITOH C, MIURA Y, HOTTA K, MUSHA T, ITOH T, MIYAKAWA T, IWASAKI R, HIRAMORI K: Deletion polymorphism of the angiotensin-I converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation 90:2199-2202, 1994
11. 11. CASTELLANO M, MUIESAN ML, RIZZONI D, BESCHI M, PASINI G, CINELLI A, SALVETTI M, PORTERI E, BETTONI G, KREUTZ R, LINDPAINTNER K, AGABITI ROSEI E: Angiotensin-converting-enzyme I/D polymorphism and arterial wall thickness in a general population: The Vobarno Study. Circulation 91:2721-2724, 1995
12. 12. CATTO A, CARTER AM, BARRETT JA, STICKLAND M, BAMFORD J, DAVIES JA, GRANT PJ: Angiotensin-converting-enzyme insertion/deletion polymorphism and cerebrovascular disease. Stroke 27: 435-440, 1996
13. 13. SCHMIDT S, SCHONE N, RITZ E, THE DIABETIC NEPHROPATHY STUDY GROUP: Association of ACE gene polymorphism and diabetic nephropathy? Kidney Int 47:1176-1181, 1995
14. 14. MCLAUGHLIN KJ, HARDEN PN, UEDA S, BOULTON-JONES M, CONNELL JMC, JARDINF AG: The role of genetic polymorphisms of angiotensin-converting-enzyme in the progression of renal disease. Hypertension 28:912-915, 1996
15. 15. INOUE I, NAKAJIMA T, WILLIAMS CS, QUACKENBUSH J, PURYEAR R, POWERS M, CHENG T, LUDWIG EH, SHARMA AM, HAIA A, JEUNEMAITRE X, LALOUEL JM: A nucleoside substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 99:1786-1797, 1997
16. 16. CAULFIELD M, LAVENDER P, FARRALL M, PATH MRC, MUNROE P, LAWSON M, TURNER P, CLARK AJL: Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 330:1629-1633, 1994
17. 17. KATSUYA T, KOIKE G, YEE TW, SHARPE N, JACKSON R, NORTON R, HORIUCHI M, PRATT RE, DZAU VE, MCMAHON S: Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet 345:1600-1603, 1995
18. 18. TARNOW L, CAMBIEN F, ROSSING P, NIELSEN FS, HANSEN BV, RICARD S, POIRIER O, PARVING H-H: Angiotensinogen gene polymorphisms in IDDM patients with diabetic nephropathy. Diabetes 45:367-369, 1996
19. 19. YOSHIDA H, MITARAI T, KAWAMURA T, KITAJIMA T, MIYAZAKI Y, NAGASAWA R, KAWAGUCHI Y, KUBO H, ICHIKAWA I, SAKAI O: Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest 96:2162-2169, 1995
20. 20. BONNARDEAUX A, DAVIES E, JEUNEMAITRE X, FERY I, CHARRU A, CLAUSER E, TIRET L, CAMBIEN F, CORVOL P, SOUBRIER F: Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 24:63-69, 1994
21. 21. BENETOS A, GAUTIER S, RICARD S, TOPOUCHIAN J, ASMAR R, POIRIER O, LAROSA E, GUIZE L, SAFAR M, SOUBRIER F, CAMBIEN F: Influence of angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients. Circulation 94:698-703, 1996
22. 22. LARAGH JH: Renin profiling for diagnosis, risk assessment, and treatment of hypertension. Kidney Int 44:1163-1175, 1993
23. 23. BATAINEH A, RAIJ L: Angiotensin II, nitric oxide, and end-organ damage in hypertension. Kidney Int 68(Suppl):S14-S19, 1998
24. 24. UNGER T, CULMAN J, GOHLKE P: Angiotensin II receptor blockade and end-organ protection: Pharmacological rationale and evidence. J Hypertens 16:S3-S9, 1998
25. 25. PONTREMOLI R, SOFIA A, TIROTTA A, RAVERA M, NICOLELLA C, VIAZZI F, BEZANTE GP, BORGIA L, BOBOLA N, RAVAZZOLO R, SACCHI G, DEFERRARI G: The deletion polymorphism of the angiotensin I-converting enzyme gene is associated with target organ damage in essential hypertension. J Am Soc Nephrol 7:2550-2558, 1996
26. 26. KARIO K, KANAI N, NISHIUMA S, FUJII T, SAITO K, MATSUO T, MATSUO M, SHIMADA K: Hypertensive nephropathy and the gene for angiotensin-converting enzyme. Arterioscler Thromb Vasc Biol 17:252-256, 1997
27. 27. FRIEDEWALD WT, LEVY RI, FREDRICKSON DS: Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972
28. 28. COCKROFI DW, GAULT MH: Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41, 1976
29. 29. KASAHARA Y, ASHIHARA Y: Colorimetry of angiotensin-1 converting enzyme activity in serum. Clin Chem 27:1922-1925, 1981
30. 30. RIGAT B, HUBERT C, CORVOL P, SOUBRIER F: PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1). Nucleic Acids Res 20:1433, 1992
31. 31. RUSS P, MAERZ W, RUZICKA V, STEIN U, GROSS W: Rapid detection of the hypertension-associated Met235-Thr allele of the human angiotensinogen gene. Hum Mol Genet 2:609-610, 1993
32. 32. MANGILI R, DEFERRARI G, DI MARIO U, GIAMPIETRO O, NAVALESI R, NOSADINI R, THE ITALIAN MICROALBUMINURIA STUDY GROUP: Prevalence of hypertension and microalbuminuria in adult type 1 (insulin dependent) diabetic patients without renal failure in Italy: Validation of screening techniques to detect albuminuria. Acta Diabetol 29:156-166, 1992
33. 33. SAHN DJ, DEMARIA A, KISSLO J, WEYMAN A: Recommendations regarding quantilation in M-mode echocardiography. Results of a survey of echocardiographic measurements. Circulation 58:1072-1083, 1978
34. 34. SCHILLER NB, SHAH PM, CRAWFORD M, DEMARIA A, DEVEREUX R, FEIGENBAUM H, GUTGESELL H, REICHEN N, SAHN D, SCHNITTGER I: Recommendations for quantitation of the left ventricle by two dimensional echocardiography: American Society of Echocardiography Committee on standards, subcommittee on quantitation of two-dimensional echocardiograms. J Am Soc Echocardiogr 2:358-367, 1989
35. 35. DEVEREUX RB, ALONSO DR, LUTAS EM, GOTTLIEB GJ, CAMPO E, SACHS I, REICHEK N: Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 57:450-458, 1986
36. 36. LEVY D, GARRISON RJ, SAVAGE DD, KANNEL WB, CASTELLI WP: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med 322:1561-1566, 1990
37. 37. KOREN MJ, DEVEREUX RB, CASALE PN, SAVAGE DD, LARAGH JH: Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 114:345-352, 1991
38. 38. KAWAGISHI T, NISHIZAWA Y, KONISHI T, KAWASAKI K, EMOTO M, SHOJI T, TABATA T, INOUE T, MORH H: High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia. Kidney Int 48:820-826, 1995
39. 39. WELDELHAG I, WIKLUND O, WIKSTRAND J: Atherosclerotic changes in the femoral and carotid arteries in familial hypercholesterolemia: Ultrasonographic assessment of intima-media thickness and plaque occurrence. Arterioscler Thromb 13:1404-1411, 1993
40. 40. KEITH NM, WAGENER HP, BARKER MW: Some different types of essential hypertension: Their course and prognosis. Am J Med Sci 197:332-343, 1939
41. 41. SNEDECOR GW, COCHRAN WG: Statistical Methods. Ames, Ames Iowa State University Press, 1967, pp 1-456
42. 42. TRYON RC, BAILEY D: Cluster Analysis. New York, McGraw-Hill Book, 1970, pp 1-347
43. 43. STAESSEN JA, GINOCCHIO G, WANG JG, SAAVEDRA AP, SOUBRIER F, VLIETINCK R, FAGARD R: Genetic variability in the renin-angiotensin system: Prevalence of alleles and genotypes. J Cardiovasc Risk 4:401-422, 1997
44. 44. BERGLUND L: A recurrent theme with a new spin: ACE polymorphism and cardiovascular disease. J Lab Clin Med 131:485-486, 1998
45. 45. SCHUNKERT H: Controversial association of left ventricular hypertrophy and the ACE I/D polymorphism: Is the mist clearing up? Nephrol Dial Transplant 13:1109-1112, 1998
46. 46. BUSJAHN A, KNOBLAUCH H, KNOBLAUCH M, BOHLENDER J, MENZ M. FAULHABER HD, BECKER A, SCHUSTER H, LUFT F: Angiotensin-converting enzyme and angiotensinogen gene polymorphisms, plasma levels, cardiac dimensions: A twin study. Hypertension 29:165-170, 1997
47. 47. FERNANDEZ-LLAMA P, POCH E, ORIOLA J, BOTEY A, RIVERA F, REVERT L: Angiotensinogen gene M235T and T174M polymorphisms in essential hypertension: Relation with target organ damage. Am J Hypertens 11:439-444, 1998
48. 48. BLOEM LJ, FOROUD TM, AMBROSIUS WT, HANNA MP, TEWKSBURY DA, PRATT JH: Association of the angiotensinogen gene to serum angiotensinogen in blacks and whites. Hypertension 29:1078-1082, 1997
49. 49. HOPKINS PN, LIFTON RP, HOLLENBERG, NK, JEUNEMAITRE X, HALLOUIN MC, SKUPPIN J, WILLIAMS CS, DLUHY RG, LALOUEL JM, WILLIAMS RR, WILLIAMS GH: Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity. J Hypertens 14:199-207, 1996
50. 50. VAN GEEL PP, PINTO YM, BULKEMA H, VAN GILST WH: Is the A1166C polymorphism of the angiotensin II type 1 receptor involved in cardiovascular disease? Eur Heart J 19(Suppl G):G13-G17, 1998
51. 51. TIRET L, BONNARDEAUX A, POIERIER O, RICARD S, MARQUES-VIDAI P, EVANS A, ARVEILER D, LUC G, KEE F, DUCIMETIERE P, SOUBRIER F, CAMBIEN F: Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet 344:910-913, 1994
52. 52. BENETOS A, CAMBIEN F, GAUTIER S, RICARD S, SAFAR M, LAURENT S, LACOLLEY P, POIRIER O, TOPOUCHIAN J, ASMAR R: Influence of the angiotensin II type 1 receptor gene polymorphism on the effects of perindopril and nitrendipine on arterial stiffness in hypertensive individuals. Hypertension 28:1081-1084, 1996
53. 53. HINGORANI AD, JIA H, STEVENS PA, HOPPER R, DICKERSON JEC, BROWN MJ: Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition. J Hypertens 13:1602-1609, 1995
54. 54. NAKAUCHI Y, SUFHIRO T, YAMAMOTO M, YASUOKA N, ARII K, KUMON Y, HAMASHIGE N, HASHIMOTO K: Significance of angiotensin I-converting enzyme and angiotensin II type 1 receptor gene polymorphisms as risk factors for coronary heart disease. Atherosclerosis 125:161-169, 1996
55. 55. TAKAMI S, KATSUYA T, RAKUGI H, SATO N, NAKATA Y, KAMITANI A, MIKI T, HIGAKI J, OGIHARA T: Angiotensin II type 1 receptor gene polymorphism is associated with increase of left ventricular mass but not with hypertension. Am J Hypertens 11:316-321, 1998
56. 56. CASTELLANO M, MUIESAN ML, BESCHI M, RIZZONI D, CINELLI A, SALVETI M, PASINI G, PORTERI E, BETTONI G, ZULLI R, AGABITI-ROSEI E: Angiotensin II type 1 receptor A/C1166 polymorphism: Relationships with blood pressure and cardiovascular structure. Hypertension 28:1076-1080, 1996
57. 57. MARRE M, JEUNEMAITRE X, GALLOIS Y, RODIER M, CHATELLIER G, SERT C, DUSSELIER L, KAHAL, Z, CHAILLOUS L, HALIMI S, MULLER A, SACKMANN H, BAUDUCEAU B, BLED F, PASSA P, ALHENC-GELAS F: Contribution of genetic polymorphism in the renin angiotensin system to the development of renal complications in insulin dependent diabetes. J Clin Invest 99:1585-1595, 1997
58. 58. RIGAT B, HUBERT C, ALHENC-GELAS F, CAMBIEN F, CORVOL P, SOUBRIER F: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346, 1990